Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment

Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or more after diagnosis. Despite aggressive multimodal therapy, consisting mostly of a combination of surgery, radiother...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Pearson, Joshua R. D., Cuzzubbo, Stefania, McArthur, Simon, Durrant, Lindy G., Adhikaree, Jason, Tinsley, Chris J., Pockley, A. Graham, McArdle, Stephanie E. B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594513/
https://ncbi.nlm.nih.gov/pubmed/33178210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.582106
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky